image
10x Genomics, Inc. TXG
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
Watchlist
$ 13.34
-5.52 %
$ 1.61 B
Market Cap
-8.78
P/E
CASH FLOW STATEMENT
-15.2 M OPERATING CASH FLOW
54.78%
Growth Rates
1Year 54.78%
3Years 58.84%
5Years 27.60%
7Years 0.00%
10Years 0.00%
133 M INVESTING CASH FLOW
138.04%
Growth Rates
1Year 138.04%
3Years 76.27%
5Years 85.39%
7Years 0.00%
10Years 0.00%
13.7 M FINANCING CASH FLOW
-13.58%
Growth Rates
1Year -13.58%
3Years -69.22%
5Years -33.53%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis 10x Genomics, Inc.
image
Net Income -255 M
Depreciation & Amortization 43.6 M
Capital Expenditures -49.5 M
Stock-Based Compensation 167 M
Change in Working Capital 17.3 M
Others 38.1 M
Free Cash Flow -64.7 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (255.1) (166.0) (58.2) (542.7) (31.3) (112.5) (18.8)
Depreciation & Amortization 43.6 33.0 28.3 19.0 7.1 3.9 4.3
Deferred Income Tax 0 0 0 1.6 0.6 0.3 0
Stock Based Compensation 166.9 136.8 96.0 48.6 13.3 2.7 1.7
Other Operating Activities 12.0 2.0 79 K 306.0 0.1 1.2 0.1
Change in Working Capital 17.3 (39.4) (87.4) (50.4) 44.8 28.0 1.9
Cash From Operations (15.2) (33.6) (21.4) (217.9) 34.6 (76.4) (10.7)
INVESTING CASH FLOW
Capital Expenditures (49.5) (131.7) (101.3) (38.4) (42.8) (6.7) (3.8)
Other Items 183.0 (219.2) (5.5) 0 0 0 0
Cash From Investing Activities 133.5 (350.9) (106.7) (38.4) (42.8) (6.7) (3.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 80 K
Total Debt Repaid 0 0 0 (37.1) 0 18.7 (0.4)
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 13.7 15.8 35.3 23.7 3.8 86.6 21.1
Cash From Financing Activities 13.7 15.8 35.3 468.9 414.6 105.4 20.6
CHANGE IN CASH
Net Change In Cash 131.9 (368.7) (92.6) 212.2 406.4 22.2 6.1
FREE CASH FLOW
Free Cash Flow (64.7) (165.3) (122.7) (256.3) (8.1) (83.1) (14.5)